European Head and Neck Cancer Therapeutics Markets

Table of Contents

1. EXECUTIVE SUMMARY

Overview

• Overview of the Head and Neck Cancer Therapeutics Market

2. GLOSSARY OF TERMS

List of Terms

• Abbreviations

3. MARKET OVERVIEW

Introduction

• Disease Characteristics
• Epidemiology

Market Definition and Segmentation

• Definition
• Segmentation

4. RESEARCH METHODOLOGY

Research Objectives and Scope

• Methodology
• Assumptions and Limitations

5. INDUSTRY CHALLENGES

Industry Challenges for the European Head and Neck Cancer Therapeutics Markets

• Challenges Faced by Pharmaceutical Companies

6. TOTAL EUROPEAN HEAD AND NECK CANCER THERAPEUTICS MARKET

Overview and Definitions

• Introduction
• Market Drivers
• Market Restraints
• Current Therapeutic Options
• Future Therapeutic Approaches
• Current Treatment Guidelines
• Pricing Trends
• Market Engineering Measurement Analysis

Competitive Analysis

• Profiles of Key Industry Participants and Market Share Analysis
• Pipeline Analysis

7. TOTAL FORECASTS FOR THE EUROPEAN HEAD AND NECK CANCER THERAPEUTICS MARKET

Forecasts

• Patient Forecasts
• Market Revenue Forecasts
• Geographical Trends
• Forecasts of Recent Entrants - Erbitux

8. PRICING AND REIMBURSEMENTS

Pricing and Reimbursement Issues

• Pricing and Reimbursement

9. STRATEGIC RECOMMENDATIONS FOR THE EUROPEAN HEAD AND NECK CANCER THERAPEUTICS MARKET

Market Engineering Recommendations

• Strategic Recommendations

10. DATABASE OF KEY INDUSTRY PARTICIPANTS

Key Industry Participants

• Key Participants in the Head and Neck Cancer Therapeutics Market

11. DECISION SUPPORT DATABASES

Habitual Indicators

• Prevalence of Smokers
• Prevalence of Male Smokers
• Prevalence of Female Smokers
• Alcohol Consumption

Healthcare Expenditure

• Expenditure
• Pharmaceutical R&D Expenditure

Demography

• Female Population Aged 65 Years and Above
• Male Population Aged 65 Years and Above
• Population Aged 65 Years and Above
• Percent of Population Aged 65 Years and Above